Literature DB >> 16644220

Thiazolo[5,4-f]quinazolin-9-ones, inhibitors of glycogen synthase kinase-3.

Alexandra Testard1, Cédric Logé, Benoît Léger, Jean-Michel Robert, Olivier Lozach, Mélina Blairvacq, Laurent Meijer, Valérie Thiéry, Thierry Besson.   

Abstract

In an effort to identify new protein kinase inhibitors with increased potency and selectivity, we have developed the microwave-assisted synthesis of thiazolo[5,4-f]quinazolin-9-ones. The effects of eighteen derivatives on CDK1/cyclin B, CDK5/p25, and GSK-3 were investigated. Several turned out to inhibit GSK-3 in the micromolar range. Molecular modeling studies suggest that the most selective GSK-3 inhibitors 7a-d bind into the ATP-binding site through a key hydrogen bond interaction with Val135 and target the specific hydrophobic backpocket of the enzyme.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16644220     DOI: 10.1016/j.bmcl.2006.04.006

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  11 in total

1.  Discovery of a novel broad-spectrum antifungal agent derived from albaconazole.

Authors:  Rémi Guillon; Fabrice Pagniez; Carine Picot; Damien Hédou; Alain Tonnerre; Elizabeth Chosson; Muriel Duflos; Thierry Besson; Cédric Logé; Patrice Le Pape
Journal:  ACS Med Chem Lett       Date:  2013-01-17       Impact factor: 4.345

Review 2.  Glycogen synthase kinase 3: more than a namesake.

Authors:  Geetha Vani Rayasam; Vamshi Krishna Tulasi; Reena Sodhi; Joseph Alex Davis; Abhijit Ray
Journal:  Br J Pharmacol       Date:  2009-03-04       Impact factor: 8.739

3.  Organocatalysis in heterocyclic synthesis: DABCO as a mild and efficient catalytic system for the synthesis of a novel class of quinazoline, thiazolo [3,2-a]quinazoline and thiazolo[2,3-b] quinazoline derivatives.

Authors:  Haider Behbehani; Hamada Mohamed Ibrahim
Journal:  Chem Cent J       Date:  2013-05-07       Impact factor: 4.215

4.  GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS.

Authors:  Hagit Eldar-Finkelman; Ana Martinez
Journal:  Front Mol Neurosci       Date:  2011-10-31       Impact factor: 5.639

5.  Diversity oriented one-pot three-component sequential synthesis of annulated benzothiazoloquinazolines.

Authors:  Mahendra Kumar; Kailash Sharma; Dinesh Kumar Sharma
Journal:  Org Med Chem Lett       Date:  2012-03-02

6.  Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part II.

Authors:  Alicia Foucourt; Damien Hédou; Carole Dubouilh-Benard; Angélique Girard; Thierry Taverne; Anne-Sophie Casagrande; Laurent Désiré; Bertrand Leblond; Thierry Besson
Journal:  Molecules       Date:  2014-09-26       Impact factor: 4.411

7.  Design and synthesis of thiazolo[5,4-f]quinazolines as DYRK1A inhibitors, part I.

Authors:  Alicia Foucourt; Damien Hédou; Carole Dubouilh-Benard; Laurent Désiré; Anne-Sophie Casagrande; Bertrand Leblond; Nadège Loäec; Laurent Meijer; Thierry Besson
Journal:  Molecules       Date:  2014-09-29       Impact factor: 4.411

8.  Development of Kinase Inhibitors via Metal-Catalyzed C⁻H Arylation of 8-Alkyl-thiazolo[5,4-f]-quinazolin-9-ones Designed by Fragment-Growing Studies.

Authors:  Florence Couly; Marine Harari; Carole Dubouilh-Benard; Laetitia Bailly; Emilie Petit; Julien Diharce; Pascal Bonnet; Laurent Meijer; Corinne Fruit; Thierry Besson
Journal:  Molecules       Date:  2018-08-29       Impact factor: 4.411

9.  Synthesis of Bioactive 2-(Arylamino)thiazolo[5,4-f]-quinazolin-9-ones via the Hügershoff Reaction or Cu- Catalyzed Intramolecular C-S Bond Formation.

Authors:  Damien Hédou; Carole Dubouilh-Benard; Nadège Loaëc; Laurent Meijer; Corinne Fruit; Thierry Besson
Journal:  Molecules       Date:  2016-06-18       Impact factor: 4.411

10.  Inhibition mechanism of CDK-2 and GSK-3β by a sulfamoylphenyl derivative of indoline-a molecular dynamics study.

Authors:  Przemysław Czeleń
Journal:  J Mol Model       Date:  2017-07-19       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.